Kelly Jia, MD
Clinical Cardiac Electrophysiology · New York, NYNPI 1477948230
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (36.3%), food and beverage and grants — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Biotronik Inc. at 31.3% of the total. 2025 is the largest year on record at $43,638, more than ten times the $152 reported in 2021.
Across 669 payments — averaging $132.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$28K
- Boston Scientific$27K
- Abbott$19K
- Medtronic$11K
- Biosense Webster, Inc.$3K
- Cardiva Medical, Inc.$750
- plus $554 from 8 others
What the payments were for
- Consulting fees$5251%
- Speaking & faculty fees$12,50014%
- Grants$17,50020%
- Travel & lodging$32,21236%
- Food & beverage$24,97328%
- Education$9411%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 127 | $27,724 |
| Boston Scientific | 173 | $26,929 |
| Abbott | 77 | $19,025 |
| Medtronic | 203 | $10,554 |
| Biosense Webster, Inc. | 52 | $3,116 |
| Cardiva Medical, Inc. | 26 | $750 |
| Endologix LLC | 1 | $136 |
| E.r. Squibb & Sons, L.L.C. | 2 | $136 |
| EBR Systems, Inc. | 1 | $98 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $74 |
| Amgen | 1 | $41 |
| Irhythm Technologies, Inc. | 1 | $33 |
| AstraZeneca | 1 | $18 |
| Philips North America LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VersaCross Access Solution$12,500
- BioMonitor$8,626
- Acticor 7 VR-T DX$7,435
- Edora 8 DR-T$6,446
- Solia$6,446
- Rivacor 7 DR-T$6,446
- EMBLEM MRI S-ICD$5,271
- GENERAL - THERAPIES$3,658
- AMPLATZER AMULET$2,070
- Carto 3$1,999
- S-ICD System Magnet$1,256
- ENSITE PRECISION$1,137
- PAMIRA$626
- AVEIR$577
- Micra$432
- AFFERA MAPPING SYSTEM$323
- Selectra$297
- Diamondback Coronary$177
- Farapulse$176
- JOT DX$171
How this compares
$88,651 in reported general payments places this provider in the 80th percentile of 214 clinical cardiac electrophysiology providers in New York.
See all clinical cardiac electrophysiology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $21,458 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in New York
- Vivek ReddyNew York$14.9M
- Jacob KoruthNew York$3.7M
- Srinivas DukkipatiNew York$2.7M
- Amir AhmadiNew York$789K
- Larry ChinitzNew York$448K
- James IpNew York$347K
- Nicholas SkipitarisNew York$293K
- Mohit TuragamNew York$202K
- David LauNew York$202K
- Christopher LiuNew York$181K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.